Sharon Faust joined Navitus in 2014, and was most recently the Senior Vice President of Specialty Pharmacy at Lumicera Health Services, a wholly-owned subsidiary of Navitus Health Solutions. Working ...

Eminent business & pharmacy executive takes helm as company readies for new product launches in 2025 LEHI, Utah, Sep ...

The FDA’s priority review voucher program for rare pediatric diseases is set to lapse on Sept. 30 without congressional intervention.

Eberle, R.Ph., M.B.A., its new president. Eberle will join CivicaScript from Navitus Health Solutions, where he currently serves as Chief Pharmacy Officer. In this role, Eberle has been instrumental ...

This analysis finds that 57.4 million adults under the age of 65 could potentially be eligible for GLP-1 drugs based on ...

The eligibility screening tool is only approved for the life of the current grant term. If a grantee is awarded funding under a subsequent grant, the grantee must resubmit their eligibility screening ...